· Журналы · Книги · О проекте ·Электронные версии книг издательства “Атмосфера” поступили в продажу Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru ИНТЕРНЕТ-МАГАЗИН    Нервные болезни 2021 / N 2 Технологии массового параллельного секвенирования в неврологии Д.Г. Сафонов, Н.Ю. Абрамычева, Я.И. Алексеев, Е.П. Нужный, Е.Ю. Федотова, С.Н. Иллариошкин References 1. Borodinov AG, Manoylov VV, Zarutskiy IV, Petrov AI, Kurochkin VE. Generations of DNA sequencing methods (review). Scientific Instrumentation 2020;30(4):3-20 (In Russian). 2. Kurnikova MA, Pavlova AV, Mann SG, Zakharova VV, Varlamova TV, Yasko LA, Abasov RH, Mersiyanova IV, Raykina EV. From molecular geneticist to physician: "translation difficulties". Russian Journal of Pediatric Hematology and Oncology 2019;6(S1):26 (In Russian). 3. Sirotko II, Volobuev AN, Romanchuk PI. Genetics and epigenetics of Alzheimer’s disease: new cognitive technologies and neurocommunications. Bulletin of Science and Practice 2021;7(2):89-111 (In Russian). 4. Agostoni EC, Barbanti P, Calabresi P, Colombo B, Cortelli P, Frediani F, Geppetti P, Grazzi L, Leone M, Martelletti P, Pini LA, Prudenzano MP, Sarchielli P, Tedeschi G, Russo A; Italian chronic migraine group. Current and emerging evidence-based treatment options for chronic migraine: a narrative overview. The Journal of Headache and Pain 2019 Aug;20(1):92. 5. Benatar M, Wu J, Andersen PM, Lombardi V, Malaspina A. Neurofilament light: candidate for biomarkers of asymptomatic amyotrophic lateral sclerosis and phenoconversion. Annals of Neurology 2018 Jul;84(1):130-9. 6. Bradley RG, Andrew AS, Trainor BJ, Chiò A, Butt TH, Stommel EW. Gene-environment-time interactions in neurodegenerative diseases: hypotheses and research approaches. Annals of Neurology 2018;25(4):261-7. 7. Feigin VL, Vos T, Nichols E, Owolabi MO, Carroll WM, Dichgans M, Deuschl G, Parmar P, Brainin M, Murray C. The global burden of neurological disorders: transforming evidence into policy. The Lancet. Neurology 2020 Mar;19(3):255-65. 8. Hoyle JK, Isforth MS, Roggenback J, Arnold VD. The genetics of Charcot–Marie–Toute disease: current trends and future implications for diagnosis and treatment. The Application of Clinical Genetics 2015 Oct;8:235-43. 9. Ilyas M. Next-generation sequencing in diagnostic pathology. Pathobiology 2017;84(6):292-305. 10. Jackson M, Marks L, May GH, Wilson JB. The genetic basis of the disease. Essays in Biochemistry 2018 Dec;62(5):643-723. 11. Jiang T, Tang MS, Tang L, Yu J. Application of new generation sequencing technologies in neurology. Annals of Translational Medicine 2014 Dec;2(12):125. 12. Kalinderi K, Bostantjopoulou S, Fidani L. The genetic background of Parkinson’s disease: current progress and prospects for the future. Acta Neurologica Scandinavica 2016 Nov;134(5):314-26. 13. Klein CJ, Foroud TM. Individualized medicine in neurology: when to use next-generation sequencing panels. Mayo Clinic Proceedings 2017 Feb;92(2):292-305. 14. Lewis P, Spillane JE. Molecular and clinical pathology of neurodegenerative diseases. London: Academic Press; 2018. 274 p. 15. Liu YT, Li YK, Soong BV. What we learned from next-generation sequencing: contributions to the genetic diagnosis and understanding of the pathomechanisms of neurodegenerative diseases. Journal of Neurogenetics 2015;29(2-3):109-12. 16. Marques Matos C, Alonso I, Leão M. Diagnostic yield of next-generation sequencing applied to neurological disorders. Journal of Clinical Neuroscience 2019 Sep;67:14-8. 17. Murphy SM, Laura M, Fawcett K, Pandraud A, Liu YT, Davidson GL, Rossor AM, Polke JM, Castleman V, Manji H, Lunn MPT, Bull K, Ramdharry G, Davis M, Blake JC, Houlden H, Reilly MM. Charcot–Marie–Toute disease: frequency of genetic subtypes and recommendations for genetic testing. Journal of Neurology, Neurosurgery, and Psychiatry 2012 Jul;83(7):706-10. 18. Nalbandian A, Donkervoort S, Dek E, Badadani M, Katheria V, Rana P, Nguyen C, Mukherjee J, Caiozzo C, Martin B, Watts GD, Vesa J, Smith C, Kimonis VE. Multiple facets of valosin-containing protein-associated diseases: including body myopathy with Paget’s bone disease, frontotemporal dementia, and amyotrophic lateral sclerosis. Journal of Molecular Neuroscience 2011 Nov;45(3):522-31. 19. Nardello R, Plicato G, Mangano GD, Gennaro E, Mangano S, Brighina F, Raieli V, Fontana A. Two distinct phenotypes, hemiplegic migraine and episodic Ataxia type 2, caused by a novel common CACNA1A variant. BMC Neurology 2020 Apr;20(1):155. 20. Nicholson AM, Rademakers R. What we know about TMEM106B in neurodegeneration. Acta Neuropathologica 2016 Nov;132(5):639-51. 21. Pang SYY, Teo KC, Hsu JS, Chang RSK, Li M, Sham PC, Ho SL. The role of gene variants in the pathogenesis of neurodegenerative disorders identified in next-generation sequencing studies: a review. Translational Neurodegeneration 2017 Oct;6(1):27. 22. Pajusalu S, Kahre T, Roomere H, Murumets Ü, Roht L, Simenson K, Reimand T, Õunap K. Sequencing of a large panel of genes in clinical diagnostics-results of 501 consecutive cases. Clinical Genetics 2018 Jan;93(1):78-83. 23. Preishe O, Schultz SA, Apel A, Kuhle J, Kaeser SA, Barro C, Gräber S, Kuder-Buletta E, LaFougere C, Laske C, Vöglein J, Levin J, Masters CL, Martins R, Schofield PR, Rossor MN, Graff-Radford NR, Salloway S, Ghetti B, Ringman JM, Noble JM, Chhatwal J, Goate AM, Benzinger TLS, Morris JC, Bateman RJ, Wang G, Fagan AM, McDade EM, Gordon BA, Jucker M; Dominantly Inherited Alzheimer Network. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease. Nature Medicine 2019 Feb;25(2):277-83. 24. Rexach J, Lee X, Martinez-Agosto JA, Németh AH, Fogel BL. Clinical application of next-generation sequencing in the practice of neurology. The Lancet. Neurology 2019 May;18(5):492-503. 25. Sakakibara R, Tateno F, Kishi M, Tsuyusaki Y, Aiba Y, Terada H, Inaoka T, Sawai S, Kuwabara S, Nomura F. Genetic screening for spinocerebellar ataxia genes in a Japanese single-hospital cohort. Journal of Movement Disorders 2017 Sep;10(3):116-22. 26. Schüle R, Wiethoff S, Martus P, Karle KN, Otto S, Klebe S, Klimpe S, Gallenmüller C, Kurzwelly D, Henkel D, Rimmele F, Stolze H, Kohl Z, Kassubek J, Klockgether T, Vielhaber S, Kamm C, Klopstock T, Bauer P, Züchner S, Liepelt-Scarfone I, Schöls L. Hereditary spastic paraplegia: clinical and genetic lessons from 608 patients. Annals of Neurology 2016 Apr;79(4):646-58. 27. Scott JG, Michalopoulos S, Erskine HE, Roberts J, Rahman A. Child mental disorders and developmental disorders. In: Mental, neurological, and substance use disorders: disease control priorities. Patel V, Chisholm D, Dua T, Laxminarayan R, Medina-Mora ME, editors. 3rd ed. Vol. 4. Washington (DC): International Bank for Reconstruction and Development / World Bank; 2016: 145-61. 28. Sun YM, Lu C, Wu ZY. Spinocerebellar ataxia: the relationship between phenotype and genotype-review. Clinical Genetics 2016 Oct;90(4):305-14.    [ Содержание выпуска N 2 | Выпуски журнала | Список журналов ]